1. 2020
  2. 2018
  3. Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Noor, A., Walser, G., Wesseling, M., Giron, P., Laffra, A-M., Haddouchi, F., De Grève, J. & Kronenberger, P., 22 Oct 2018, In : BMC Research Notes. 11, 1, 7 p., 751.

    Research output: Contribution to journalArticle

  4. Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer

    Noor, A., Umelo, I. A., Kronenberger, P., Giron, P., De Vlieghere, E., De Wever, O., Teugels, E. & De Grève, J., 19 Jun 2018, In : Oncotarget. 9, 47, p. 28731-28744 14 p.

    Research output: Contribution to journalArticle

  5. 2017
  6. Targeting polo-like kinase 1 and TRAIL to enhance apoptosis in non-small cell lung cancer (NSCLC) cells.

    Noor, A., Umelo, I. A., Kronenberger, P., Teugels, E. & De Greve, J., 20 May 2017, In : Journal of Clinical Oncology. 35, p. 28731-28744 14 p.

    Research output: Contribution to journalMeeting abstract (Journal)

  7. 2015
  8. Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade

    Umelo, I. A., De Wever, O., Kronenberger, P., Van Deun, J., Noor, A., Singh, K., Teugels, E., Chen, G., Bracke, M. & De Grève, J., 21 Aug 2015, In : Oncotarget. 6, 24, p. 20132-20144 13 p.

    Research output: Contribution to journalArticle

  9. 2014
  10. 2013
  11. 2012
Previous 1 2 3 4 Next

ID: 89911